mhurhangee/ep-ind-claims huggingface dataset:
An irrigation system for ultrasonic cleansing of an internal body part, comprising: a. an irrigator comprising: an ultrasonic transducer, an inlet and an outlet; b. at least one control unit comprising: at least one power supply configured for supplying power at least to the control unit; c. a liquid supply configured for storing liquid; d. a nanoparticles supply configured for storing one or more nanoparticle powders; e. a pump configured for: supplying at least one selected from said liquid from the liquid supply to a body cavity via the irrigator inlet and said nanoparticles from said nanoparticles supply; and/or for extracting at least one selected from said liquid, said nanoparticles and any combination thereof from the body cavity; and f. a control circuitry configured for coupling to one or more of: the power supply, the liquid supply, the nanoparticles supply and the pump; wherein the control circuitry and the at least one power supply are further configured for coupling to the ultrasonic transducer, the ultrasonic transducer being configured to contact the liquid; wherein said control circuitry is configured to initiate said ultrasonic transducer that generates imploding cavitation bubbles creating micro-jets in said liquid when said nanoparticles are suspended therein, resulting in bombarding surfaces of said internal body part with said nanoparticles to clean and disinfect the same. a. an irrigator comprising: an ultrasonic transducer, an inlet and an outlet; b. at least one control unit comprising: at least one power supply configured for supplying power at least to the control unit; c. a liquid supply configured for storing liquid; d. a nanoparticles supply configured for storing one or more nanoparticle powders; e. a pump configured for: supplying at least one selected from said liquid from the liquid supply to a body cavity via the irrigator inlet and said nanoparticles from said nanoparticles supply; and/or for extracting at least one selected from said liquid, said nanoparticles and any combination thereof from the body cavity; and f. a control circuitry configured for coupling to one or more of: the power supply, the liquid supply, the nanoparticles supply and the pump; wherein the control circuitry and the at least one power supply are further configured for coupling to the ultrasonic transducer, the ultrasonic transducer being configured to contact the liquid; wherein said control circuitry is configured to initiate said ultrasonic transducer that generates imploding cavitation bubbles creating micro-jets in said liquid when said nanoparticles are suspended therein, resulting in bombarding surfaces of said internal body part with said nanoparticles to clean and disinfect the same.
A method of welding an electrode tab, the method comprising: preparing an electrode stack with an insulating layer, a current collecting layer, and a primer layer, sequentially provided; forming an electrode active material layer which is provided on the primer layer and has a region in which the primer layer is exposed; laminating an electrode tab in the region in which the primer layer is exposed; and welding the electrode tab and the current collecting layer by irradiating a pulsed laser beam, wherein transmittance of the insulating layer is 50% or more at a wavelength of 400 nm to 1,200 nm, and the pulsed laser beam penetrates through the insulating layer and is emitted in a direction from the insulating layer to the current collecting layer, wherein pulse energy of the pulsed laser beam is 10 mJ to 30 mJ, wherein a spot spacing distance of the pulsed laser beam in a longitudinal direction is 0.15 mm to 0.45 mm, and wherein a spot spacing distance of the pulsed laser beam in a width direction of the electrode is 0.15 mm to 0.35 mm. preparing an electrode stack with an insulating layer, a current collecting layer, and a primer layer, sequentially provided; forming an electrode active material layer which is provided on the primer layer and has a region in which the primer layer is exposed; laminating an electrode tab in the region in which the primer layer is exposed; and welding the electrode tab and the current collecting layer by irradiating a pulsed laser beam, wherein transmittance of the insulating layer is 50% or more at a wavelength of 400 nm to 1,200 nm, and the pulsed laser beam penetrates through the insulating layer and is emitted in a direction from the insulating layer to the current collecting layer, wherein pulse energy of the pulsed laser beam is 10 mJ to 30 mJ, wherein a spot spacing distance of the pulsed laser beam in a longitudinal direction is 0.15 mm to 0.45 mm, and wherein a spot spacing distance of the pulsed laser beam in a width direction of the electrode is 0.15 mm to 0.35 mm.
A transgenic mouse whose genome comprises: (a) a stably integrated complete human λ light chain locus spanning 0.9 Mb, wherein said λ light chain locus is in germline configuration; (b) a stably integrated portion of a human κ light chain locus in germline configuration, wherein said portion is the human κ light chain locus as found in XenoMouse IIa; (c) a stably integrated portion of a human immunoglobulin heavy chain locus in germline configuration, wherein said portion is the human immunoglobulin heavy chain locus as found in XenoMouse IIa, except that the Cγ constant region genes are; human Cγ1 constant region genes, or human Cγ4 constant region genes; (d) homozygous inactivated endogenous immunoglobulin heavy chain loci; and (e) homozygous inactivated endogenous immunoglobulin κ light chain loci. (a) a stably integrated complete human λ light chain locus spanning 0.9 Mb, wherein said λ light chain locus is in germline configuration; (b) a stably integrated portion of a human κ light chain locus in germline configuration, wherein said portion is the human κ light chain locus as found in XenoMouse IIa; (c) a stably integrated portion of a human immunoglobulin heavy chain locus in germline configuration, wherein said portion is the human immunoglobulin heavy chain locus as found in XenoMouse IIa, except that the Cγ constant region genes are; human Cγ1 constant region genes, or human Cγ4 constant region genes; (d) homozygous inactivated endogenous immunoglobulin heavy chain loci; and (e) homozygous inactivated endogenous immunoglobulin κ light chain loci.
A syringe having a container for storing an injectable medication and with forward and rearward ends, a plunger that is movable axially within the container body and an injection needle extending forwardly from the body, and characterized in that: the plunger and body are flat, in that each has a thickness transverse to the axis that is substantially less than their width transverse to the axial direction and the thickness direction or their axial length, and the injection needle extends forwardly from the plunger. the plunger and body are flat, in that each has a thickness transverse to the axis that is substantially less than their width transverse to the axial direction and the thickness direction or their axial length, and the injection needle extends forwardly from the plunger.
A bearing ring for a roller bearing defining a guiding flange and a raceway, wherein the bearing ring comprises a retainer element (120, 120a-c) that is removably engageable with the raceway, characterized in that said retainer element (120, 120a-c) is removably engageable with an engagement feature (124, 124a-c, 106) defined by the bearing ring, at at least one location on the bearing ring, to modify or adjust the raceway width to accommodate different sized rolling elements in different bearings showing the same basic configuration of inner and outer rings.
A pharmaceutical composition comprising at least two different lytic bacteriophage each selected from a different group, wherein the groups consist of: a) a bacteriophage having a genomic sequence as set forth in SEQ ID NO: 21, 22, 23, 24, 25, 26, 27, 28 or 29, and any other lytic bacteriophage that has at least 83% homology as determined by BLAST to any of the foregoing bacteriophage in a) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain, b) a bacteriophage having a genomic sequence as set forth in SEQ ID NO: 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51 or 52, and any other lytic bacteriophage that has at least 85% homology as determined by BLAST to any of the foregoing bacteriophage in b) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain, and c) SEQ ID NO: 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 or 40, and any other lytic bacteriophage that has at least 86% homology as determined by BLAST to any of the foregoing bacteriophage in c) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain, wherein the pharmaceutical composition is formulated for delivery to a mammalian intestine or formulated for delivery to a mammalian mouth. a) a bacteriophage having a genomic sequence as set forth in SEQ ID NO: 21, 22, 23, 24, 25, 26, 27, 28 or 29, and any other lytic bacteriophage that has at least 83% homology as determined by BLAST to any of the foregoing bacteriophage in a) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain, b) a bacteriophage having a genomic sequence as set forth in SEQ ID NO: 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51 or 52, and any other lytic bacteriophage that has at least 85% homology as determined by BLAST to any of the foregoing bacteriophage in b) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain, and c) SEQ ID NO: 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 or 40, and any other lytic bacteriophage that has at least 86% homology as determined by BLAST to any of the foregoing bacteriophage in c) and is capable of lytic infection of a Klebsiella pneumoniae 2H7 bacterial strain or a bacterial strain having greater than 85 % homology to said Klebsiella pneumoniae 2H7 bacterial strain,
An antimicrobial personal cleansing composition comprising: (i) an aqueous continuous phase including one or more anionic cleansing surfactants; (ii) a dispersed phase including dispersed particles of zinc pyrithione; (iii) a structuring polymer for the aqueous continuous phase which is selected from crosslinked alkali-swellable acrylic emulsion polymers; and (iv) from 3 to 20 wt% niacinamide based on the total weight of the composition, wherein the structuring polymer is selected from crosslinked copolymers of (meth)acrylic acid with one or more C1 to C5 alkyl esters of (meth)acrylic acid. (i) an aqueous continuous phase including one or more anionic cleansing surfactants; (ii) a dispersed phase including dispersed particles of zinc pyrithione; (iii) a structuring polymer for the aqueous continuous phase which is selected from crosslinked alkali-swellable acrylic emulsion polymers; and (iv) from 3 to 20 wt% niacinamide based on the total weight of the composition,
Magazine attachment for a device for driving fastening elements into a substrate, with an extension member having a connecting region for connecting the magazine attachment to the device, and a pressure application part having an abutment region for applying the magazine attachment to the substrate, the extension member and the pressure application part being held together displaceably along a displacement path, the displacement path being delimited by a normal position and a pressure application position, characterised in that an outer contour of the pressure application part has three contact points which define two half-lines encompassing a right-angled angle field, and the extension member and the pressure application part being located, in the normal position and in the pressure application position, entirely within a volume encompassed by the angle field and a straight line intersecting the two half-lines at the vertex of the angle field.
A steel Yankee drying cylinder comprising a cylindrical shell having two axial ends (4, 5), an end wall (6, 7) being joined to each axial end (4, 5) by means of a circumferential weld bead, the cylindrical shell further having an outer surface and an inner surface, characterized in that the outer surface of the cylindrical shell is formed by steel of the grade P690 as defined in European Standard EN 10028-6:2017 or a similar steel which has the following composition by weight: C equal to or greater than 0.12 % and equal to or less than 0.20 % Si equal to or greater than 0.10 % and equal to or less than 0.80 % Mn equal to or greater than 1.00 % and equal to or less than 1.70 % Cr equal to or greater than 0.10 % and equal to or less than 1.50 % Mo equal to or greater than 0.30 % and equal to or less than 0.70 % V equal to or greater than 0.005 % and equal to or less than 0.12 % Nb equal to or greater than 0.005 % and equal to or less than 0.060 % B equal to or greater than 0.0006 % and equal to or less than 0.005 % P equal to or less than 0.025 % S equal to or less than 0.010 % N equal to or less than 0.015% Cu equal to or less than 0.30 % Ni equal to or less than 2.50 % Ti equal to or less than 0.05 % Zr equal to or less than 0.15 % Al equal to or less than 0.01% Remainder iron and impurities. C equal to or greater than 0.12 % and equal to or less than 0.20 % Si equal to or greater than 0.10 % and equal to or less than 0.80 % Mn equal to or greater than 1.00 % and equal to or less than 1.70 % Cr equal to or greater than 0.10 % and equal to or less than 1.50 % Mo equal to or greater than 0.30 % and equal to or less than 0.70 % V equal to or greater than 0.005 % and equal to or less than 0.12 % Nb equal to or greater than 0.005 % and equal to or less than 0.060 % B equal to or greater than 0.0006 % and equal to or less than 0.005 % P equal to or less than 0.025 % S equal to or less than 0.010 % N equal to or less than 0.015% Cu equal to or less than 0.30 % Ni equal to or less than 2.50 % Ti equal to or less than 0.05 % Zr equal to or less than 0.15 % Al equal to or less than 0.01% Remainder iron and impurities.
A photonic monobit analog-to-digital converter (300, 500), comprising: an incoherent optical source (304, 504) configured to generate an optical noise signal, the optical noise signal comprising random signal phases that are uniformly distributed over a range of the optical noise signal; an optical modulator (302, 502) configured to modulate an analog input electrical signal onto an input optical signal to generate an optical modulated signal; a coupler (306, 506) configured to couple the optical modulated signal with the optical noise signal to generate at least one coupled signal (332, 334); a photodetector (314, 514) configured to generate a phase difference between the optical modulated signal and the optical noise signal using the at least one coupled signal; a limiter (316, 516) configured to output a decision signal (346, 524) based on the phase difference; and a digital signal processing, DSP, circuit (318, 520) configured to generate a digital signal (348, 526) representative of the analog input electrical signal based on the decision signal. an incoherent optical source (304, 504) configured to generate an optical noise signal, the optical noise signal comprising random signal phases that are uniformly distributed over a range of the optical noise signal; an optical modulator (302, 502) configured to modulate an analog input electrical signal onto an input optical signal to generate an optical modulated signal; a coupler (306, 506) configured to couple the optical modulated signal with the optical noise signal to generate at least one coupled signal (332, 334); a photodetector (314, 514) configured to generate a phase difference between the optical modulated signal and the optical noise signal using the at least one coupled signal; a limiter (316, 516) configured to output a decision signal (346, 524) based on the phase difference; and a digital signal processing, DSP, circuit (318, 520) configured to generate a digital signal (348, 526) representative of the analog input electrical signal based on the decision signal.
A sulfur-modified chloroprene rubber comprising a functional group A represented by General Formula below and positioned at a molecular terminal and a functional group B represented by General Formula below and positioned at a molecular terminal, wherein a mass ratio B/A of a content of the functional group B with respect to a content of the functional group A is more than 0 and 6.00 or less, and a total amount of the functional group A and the functional group B is 0.10 to 0.60% by mass. (In the formula, R a1 and R a2 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, a carboxy group, a carboxylate group, a cyano group, an alkyl group which may have a substituent, or an arylthio group which may have a substituent, and R a1 and R a2 may bond with each other to form a ring which may have a substituent.) (In the formula, R b1 and R b2 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, a carboxy group, a carboxylate group, a cyano group, an alkyl group which may have a substituent, or an arylthio group which may have a substituent, and R b1 and R b2 may bond with each other to form a ring which may have a substituent.) a mass ratio B/A of a content of the functional group B with respect to a content of the functional group A is more than 0 and 6.00 or less, and a total amount of the functional group A and the functional group B is 0.10 to 0.60% by mass. (In the formula, R a1 and R a2 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, a carboxy group, a carboxylate group, a cyano group, an alkyl group which may have a substituent, or an arylthio group which may have a substituent, and R a1 and R a2 may bond with each other to form a ring which may have a substituent.) (In the formula, R b1 and R b2 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, a carboxy group, a carboxylate group, a cyano group, an alkyl group which may have a substituent, or an arylthio group which may have a substituent, and R b1 and R b2 may bond with each other to form a ring which may have a substituent.)
A method of providing an optimal surfactant blend to improve waterflood efficiency, wherein the method is characterized by: selecting candidate surfactant blends based on information of a crude oil and information of an injection fluid, wherein each candidate surfactant blend comprises at least a first surfactant which has a higher relative affinity for the crude oil than for the injection fluid and at least a second surfactant which has a higher relative affinity for the injection fluid than for the crude oil; evaluating the phase behavior of the candidate surfactant blends by blending the candidate surfactant blends with the crude oil and the injection fluid at a reservoir temperature, and selecting surfactant blends that form a Winsor III system having an oil phase, an aqueous phase, and a microemulsion in a separate phase between the oil phase and the aqueous phase; and evaluating the selected surfactant blends in a sand-pack cell or a coreflood unit to select an optimal surfactant blend which achieves at least an additional 10% crude oil recovery after waterflood in a sand pack or coreflood test. selecting candidate surfactant blends based on information of a crude oil and information of an injection fluid, wherein each candidate surfactant blend comprises at least a first surfactant which has a higher relative affinity for the crude oil than for the injection fluid and at least a second surfactant which has a higher relative affinity for the injection fluid than for the crude oil; evaluating the phase behavior of the candidate surfactant blends by blending the candidate surfactant blends with the crude oil and the injection fluid at a reservoir temperature, and selecting surfactant blends that form a Winsor III system having an oil phase, an aqueous phase, and a microemulsion in a separate phase between the oil phase and the aqueous phase; and evaluating the selected surfactant blends in a sand-pack cell or a coreflood unit to select an optimal surfactant blend which achieves at least an additional 10% crude oil recovery after waterflood in a sand pack or coreflood test.
A media server system comprising: a computer, including a media server which can receive requests from media device clients for media content; and a media content bot provided within a social messaging environment that supports group chat, which is arranged to support an interaction with a plurality of users (192, 290) as part of a group chat in the social messaging environment, and in response to the interaction with the plurality of users as part of the group chat, the media content bot is arranged to access the media server for determining one or more recommended items of media content, and streaming, downloading, accessing, or otherwise using the recommended media content; wherein the media server system is arranged to enable use of media playback controls within the group chat, enabling the plurality of users to determine which media content to be played; and wherein the media server system is arranged to enable the plurality of users (192, 290) to engage, at the same time, with the media content bot as part of the group chat, to control music playback or to receive music recommendations. a computer, including a media server which can receive requests from media device clients for media content; and a media content bot provided within a social messaging environment that supports group chat, which is arranged to support an interaction with a plurality of users (192, 290) as part of a group chat in the social messaging environment, and in response to the interaction with the plurality of users as part of the group chat, the media content bot is arranged to access the media server for determining one or more recommended items of media content, and streaming, downloading, accessing, or otherwise using the recommended media content;
A microplasma spray method for remanufacturing a turbine engine cast superalloy component which has lost material from a substrate due to cracking or erosion, the method comprising: providing a microplasma gun including an anode and a cathode; injecting inert arc gas from a nozzle; generating an electric arc between the anode and the cathode through the arc gas; ionizing the arc gas with the electric arc to form a plasma gas stream; injecting powdered material into the plasma gas stream, and directing the plasma gas stream to the substrate to form a deposit from said powdered material, wherein: the material comprises first and second component powders, the second powder being a majority, by weight, of the powdered material and the first powder acting as a melting point depressant for the second powder. providing a microplasma gun including an anode and a cathode; injecting inert arc gas from a nozzle; generating an electric arc between the anode and the cathode through the arc gas; ionizing the arc gas with the electric arc to form a plasma gas stream; injecting powdered material into the plasma gas stream, and directing the plasma gas stream to the substrate to form a deposit from said powdered material, wherein: the material comprises first and second component powders, the second powder being a majority, by weight, of the powdered material and the first powder acting as a melting point depressant for the second powder. the material comprises first and second component powders, the second powder being a majority, by weight, of the powdered material and the first powder acting as a melting point depressant for the second powder.